Skip to main content
Toggle navigation
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Sig Meeting
Like
Tweet
Print
Elimor Brand-Schieber, PhD, MS
AbbVie Inc., North Chicago, IL, USA
Poster(s):
(T 40) Ubrogepant Efficacy Based on Historical Cutaneous Allodynia and Triptan Response: Results from the PRODROME Trial
(T 41) Efficacy of Ubrogepant 100 mg Based on Prior Triptan Experience: Results From the ACHIEVE I Study
